WallStSmart
COR

Cencora Inc.

NYSE: COR · HEALTHCARE · MEDICAL DISTRIBUTION

$281.67
+0.07% today

Updated 2026-06-12

Market cap
$51.53B
P/E ratio
20.28
P/S ratio
0.16x
EPS (TTM)
$13.06
Dividend yield
0.87%
52W range
$244 – $376
Volume
1.8M

Cencora Inc. (COR) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Revenue$61.20B$66.07B$70.19B$71.76B$77.95B$80.22B$79.49B$87.96B$119.57B$135.96B$146.85B$153.14B$167.94B$179.59B$189.89B$213.99B$238.59B$262.17B$293.96B$321.33B
Revenue growth (YoY)+8.0%+6.2%+2.2%+8.6%+2.9%-0.9%+10.7%+35.9%+13.7%+8.0%+4.3%+9.7%+6.9%+5.7%+12.7%+11.5%+9.9%+12.1%+9.3%
Cost of revenue$59.10B$63.87B$68.24B$69.74B$75.70B$77.79B$76.98B$85.64B$116.80B$132.75B$143.08B$149.00B$163.83B$175.06B$185.10B$207.72B$230.99B$254.42B$285.26B$311.19B
Gross profit$2.10B$2.20B$1.95B$2.02B$2.25B$2.43B$2.51B$2.32B$2.77B$3.22B$3.77B$4.15B$4.11B$4.53B$4.79B$6.27B$7.60B$7.76B$8.70B$10.14B
Gross margin3.4%3.3%2.8%2.8%2.9%3.0%3.2%2.6%2.3%2.4%2.6%2.7%2.4%2.5%2.5%2.9%3.2%3.0%3.0%3.2%
R&D
SG&A$1.40B$1.41B$5.47M$6.46M$20.83M$41.06M$44.62M$46.98M$48.24M$55.25M$58.00M$61.67M$67.79M$76.39M$80.57M$3.59B$4.85B$5.31B$5.66B$6.49B
Operating income$727.93M$786.61M$823.54M$899.13M$1.09B$1.23B$1.28B$989.02M$1.19B$1.31B$1.68B$2.02B$1.65B$1.87B$2.02B$2.68B$2.75B$2.45B$3.04B$3.65B
Operating margin1.2%1.2%1.2%1.3%1.4%1.5%1.6%1.1%1.0%1.0%1.1%1.3%1.0%1.0%1.1%1.3%1.2%0.9%1.0%1.1%
EBITDA$846.14M$960.43M$928.80M$977.61M$1.20B$1.33B$1.40B$1.07B$939.18M$630.77M$1.92B$1.49B$1.87B$1.65B$-4.73B$2.91B$3.11B$3.41B$3.36B$3.74B
EBITDA margin1.4%1.5%1.3%1.4%1.5%1.7%1.8%1.2%0.8%0.5%1.3%1.0%1.1%0.9%-2.5%1.4%1.3%1.3%1.1%1.2%
EBIT$753.09M$860.76M$836.44M$887.58M$1.10B$1.21B$1.26B$899.51M$751.13M$380.99M$1.54B$1.07B$1.37B$1.16B$-5.14B$2.40B$2.42B$2.44B$2.25B$2.68B
Interest expense$12.46M$75.71M$75.10M$63.50M$74.81M$78.90M$97.22M$75.05M$77.70M$112.02M$144.35M$149.04M$189.64M$195.47M$158.52M$182.54M$231.98M$275.65M$248.68M$419.75M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$467.71M$469.17M$250.56M$503.40M$636.75M$706.62M$718.99M$433.71M$276.48M$-134.89M$1.43B$414.48M$1.66B$855.37M$-3.40B$1.54B$1.70B$1.75B$1.51B$1.55B
Net income growth (YoY)+0.3%-46.6%+100.9%+26.5%+11.0%+1.7%-39.7%-36.3%-148.8%+1158.6%-71.0%+300.1%-48.4%-497.4%+145.3%+10.3%+2.7%-13.5%+3.0%
Profit margin0.8%0.7%0.4%0.7%0.8%0.9%0.9%0.5%0.2%-0.1%1.0%0.3%1.0%0.5%-1.8%0.7%0.7%0.7%0.5%0.5%

Frequently asked questions

What is Cencora Inc.'s revenue?

Cencora Inc.'s trailing twelve-month revenue is $328.68B. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is COR?

In its most recent fiscal year, COR ran a gross margin of 3.16%, an operating margin of 1.14%, and a net margin of 0.48%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does COR generate?

COR produced $3.21B in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is COR's balance sheet healthy?

COR holds $4.39B in cash and equivalents against $7.54B in long-term debt, on $1.51B of shareholder equity. That debt is best read against the cash flow the business throws off each year.